BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Lung
,
Laser capture microdissection
,
Lipitor
,
rs3825942
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ipilimumab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
MYBL2
TOP2A
MKI67
STRIP2
ARNTL2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
MODULE_54
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
FAN_EMBRYONIC_CTX_NSC_2
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
CD4+ T cells from PBMCs of metastatic melanoma patients after ipilimumab treatment
Prostate cancer biopsies before and after treatment with leuprolide acetate and ipilimumab
Explore Curated Studies Results
Literature
Most Relevant Literature
Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced …
TILs Outperform Ipilimumab in Melanoma.
Ipilimumab Combination Dosing: Less is More.
Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date.
Efficacy of ipilimumab 3 mg/kg following progression on low-dose ipilimumab in metastatic melanoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ipilimumab and Lenalidomide in Advanced Cancer
Ipilimumab + Temozolomide in Metastatic Melanoma
Study of Ipilimumab in the Immune System
Doxycycline, Temozolomide and Ipilimumab in Melanoma
Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ